Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04114331
Other study ID # 15-0098
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 26, 2018
Est. completion date December 20, 2019

Study information

Verified date August 2019
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately readmission. This patient population was found to be not feasible to recruit and the study target population was expanded to include older community dwelling adults with pneumonia, chronic obstructive pulmonary disease (COPD), or hyperkyphosis.


Description:

This original study was a feasibility study to determine the ability to recruit and to assess pilot data to determine the effects of a physical therapy intervention on physical function, gait, balance, posture, pulmonary function, and quality of life. Additionally the 30 day readmission, ER visits, and mortality was to be tracked. This study failed due to lack of recruitment. However, the aim to examine the effectiveness a physical therapy intervention was still used just in a broader population. The intervention and measures remained the same except for 30 day admission/mortality data.

The new aim was to examine the effectiveness of manual therapy and exercise on posture, function, gait, pulmonary function, and quality of life in older community dwelling adults with hyperkyphosis or forward head posture. Kyphosis, osteoporosis, decreased trunk flexibility, and pain are considered potential causes of restrictive lung function. The physical therapy intervention targets both soft tissue and skeletal restrictions to improve mobility. The outcomes were chosen to examine not only the direct impact on posture but also the indirect impact on physical function including pulmonary status. Lastly, cognitive mapping was used to record the change in the perceptions of the participants as they improved.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date December 20, 2019
Est. primary completion date April 18, 2019
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- at least 50 years of age

- hyperkyphosis, forward head posture, pneumonia, or chronic obstructive pulmonary disease (COPD)

- community dwelling

- self report of ability to walk 10 feet or greater with or without an assistive device

- ability to perform informed consent

- ability to transport to research facility

- ability to read and write in English or Spanish

Exclusion Criteria:

- Inability to perform informed consent

- Inability to follow directions

- Inability to perform transfers, sit, and stand independently

- Inability to ambulate 10 feet or more with or without an assistive device

- Inability to perform pulmonary function testing

- Inability to fully participate in testing and measures

- Inability to fully participate in the intervention

- Severe claustrophobia

- Unable to tolerate physical touch

- Morbid obesity (BMI greater than 40)

- History of prior lung disease such as cancer or transplant

- History of comorbidity that would affect lung function such as neuromuscular disease (ALS, MS), collagen disease (SLE), cardiovascular disease (CHF), or musculoskeletal disease with an autoimmune component (Ankylosing Spondylosis, RA).

- A prior discharge within 30 days of hospitalization for pneumonia or COPD

- Discharge against medical advice

Study Design


Intervention

Other:
Manual therapy and exercise
Manual therapy consisting of soft tissue and joint mobilization to gain mobility. Therapeutic exercise was active motion and resisted motion to gain motor control and motor coordination in the new range.

Locations

Country Name City State
United States School of Health Professions at the University of Texas Medical Branch Galveston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Weight measured in pounds through study completion (4 weeks) and one time follow-up at an average of 6 months
Primary Posture, as measured by change in height Height in cm through study completion (4 weeks) and one time follow-up at an average of 6 months
Primary Posture, as measured by change in kyphotic index kyphotic index = (thoracic width/thoracic height) *100 as measured from flexicurve tracing. A flexible ruler is molded to the posterior spine from C7 to the lumbosacral interspace. Ruler is placed on paper and traced. Measures of the thoracic width and height are taken in centimeters. through study completion (4 weeks) and one time follow-up at an average of 6 months
Primary Posture, as measured by change in block test height of blocks (measured in cm) under the head with participant supine through study completion (4 weeks) and one time follow-up at an average of 6 months
Primary Posture, visual change in digital photos Digital photo in standing anterior and side views as well as supine view through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Function as a change in Timed Up and Go speed Timed Up and Go as measured in seconds to performed standardized functional test. Participants are timed in seconds from sitting in a chair to standing, walking 3 meters, turning around, walking back, and sitting down. through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Function as a change in Functional Reach test Functional reach as measured in cm. It is performed by having the participant standing still and is instructed to reach forward as far as you can without taking a step. through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Function as a change in the Short Physical Performance Battery (SPPB) score SPPB score as determined by seconds to perform each component of this standardized test. This functional test has 3 components of 5 times sit to stand, gait speed, and balance. 5 times sit to stand is a standardized test of lower extremity strength that is performed by rising and sitting in a chair 5 times in a row. The activity is timed. Gait speed will be extracted from gaitrite data. Balance tests will be timed. through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Function and Gait as a change in the 2 Minute Walk Test (2MWT) 2MWT is the measured as the distance (feet) covered in 2 minutes through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Function and patient perception as change in the Patient Specific Functional Scale (PSFS) PSFS is a standardized survey of activities that are difficult to perform (listed by participant) and to what degree as measured on a likert scale (0 to 10) through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Gait as measured by change in gait parameters on a Gaitrite walkway The gaitrite records a standard set of parameters. Change in gait speed (m/sec), step length (cm), stride length (cm), double limb support time (seconds), and step width (cm) through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Gait as measured by change in Tekscan measures of force Tekscan records a standard set of measures of time and force. Change in peak force at loading response, mid-stance, and terminal stance in newtons. through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Pulmonary function change measure by spirometry Spirometry provides standard measures of respiratory volume and volume in time. Changes in Forced Vital Capacity and Forced Expiratory Volume in 1 second were the measures of interest. through study completion (4 weeks) and one time follow-up at an average of 6 months
Secondary Patient perception as measured by changes in Cognitive Mapping Cognitive mapping provides the issues, concerns, and perceptions of the participants of how posture affects their life. Measured by words recorded and qualitative analysis. through study completion (4 weeks) and one time follow-up at an average of 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06000696 - Healthy at Home Pilot
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04105075 - COPD in Obese Patients
Recruiting NCT05825261 - Exploring Novel Biomarkers for Emphysema Detection
Active, not recruiting NCT04075331 - Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial Phase 2/Phase 3
Terminated NCT03640260 - Respiratory Regulation With Biofeedback in COPD N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
Withdrawn NCT04210050 - Sleep Ventilation for Patients With Advanced Hypercapnic COPD N/A
Terminated NCT03284203 - Feasibility of At-Home Handheld Spirometry N/A
Recruiting NCT06110403 - Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness Phase 1/Phase 2
Active, not recruiting NCT06040424 - Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Completed NCT04485741 - Strados System at Center of Excellence
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A